Peter Dandliker, based in Boston, MA, US, is currently a Chief Operating Officer at Passkey Therapeutics, bringing experience from previous roles at Dewpoint Therapeutics and Merck. Peter Dandliker holds a 1990 - 1992 Ph.D. @ UC Los Angeles. With a robust skill set that includes Strategic Planning, Sales, Drug Discovery, R&d, Biochemistry and more, Peter Dandliker contributes valuable insights to the industry. Peter Dandliker has 1 email and 1 mobile phone number on RocketReach.